新华社:数字医疗步入成熟,医药电商将进入细分化、定制化阶段

2021-02-06 新华社 新华社

 

在近日举行的世界经济论坛“达沃斯议程”对话会上,毕马威亚太区及中国主席陶匡淳对中国医疗行业的趋势与变化做出研判认为,数字化医疗在政策利好与新冠肺炎疫情叠加影响下迎来发展春天,中国的数字化医疗发展在逐步成熟。

《经济参考报》记者采访多位业内人士了解到,在疫情的催化下,我国数字医疗发展迅速,未来发展空间巨大。与此同时,作为数字医疗重要组成部分的医药电商行业未来将进入细分化、定制化的新发展阶段。

医药电商行业进入新发展阶段

数字医疗是指把现代计算机技术、信息技术应用于整个医疗过程的一种新型现代化医疗方式,是公共医疗的发展方向和管理目标。随着互联网技术的成熟,医药电商和互联网医疗迅速进入人们的视野,成为人们数字医疗的主要形式。

陶匡淳认为,在政策鼓励、经济发展、社会发展和技术提升多重驱动下,医疗健康服务模式正在向以患者为中心的模式进行转变,制药企业也在探索以患者为中心的数字化生态系统建设。总体来说,中国的数字化医疗版图在逐步成熟。

“互联网+医药”的快速发展满足了人们足不出户便能购买所需药品的生活需求。通过电商平台购入药品的模式属于典型的“B2C”模式,它是Business-to-Consumer的缩写,指的是直接面向消费者销售产品和服务商业零售模式,是目前较为普遍的一种电商模式。

中央财经大学中国互联网经济研究院副院长欧阳日辉在接受《经济参考报》记者采访时表示,当今数字医疗的商业逻辑已经产生转变,主要表现在以下三个方面。从“C端扩张”到“B端赋能”:我国医药电商行业过去主要依赖“C端”接入人数增多、带动药品销量提升的商业模式遭到一定的发展局限,医药电商“B端”增速明显;从“渠道规模”到“供应链价值”:业界企业纷纷跨界合作,让我国医药电商行业从“单打独斗”转向通过利用供应链管理实现多元竞合的未来行业格局;从“流量营销”发展到“用户为王”:我国医药电商行业将逐渐从严肃的营销话语向以用户为核心、加强与消费者沟通的方向转变,整个行业开始进入“以人为本”、“细分化”和“定制化”的新发展阶段。

2020年12月15日,国家卫健委、国家医疗保障局、国家中医药管理局联合发布《关于深入推进“互联网+医疗健康”“五个一”服务行动的通知》,要求推进“一体化”共享服务,提升便捷化智能化人性化服务水平;推进“一码通”融合服务,破除多码并存互不通用信息壁垒;推进“一站式”结算服务,完善“互联网+”医疗在线支付工作;推进“一网办”政务服务,化解办事难、办事慢、办事繁问题;推进“一盘棋”抗疫服务,加强常态化疫情防控信息技术支撑。

企业加快构建数字医疗产业模式

与原来去医院就诊的方式相比,“互联网+医疗”的模式通过为人们提供了患者和医生共同的在线社区、在线问诊的渠道和慢病的有效管理等让人们的生活更加便捷。

互联网医疗发挥自身远程问诊优势开展大规模的线上咨询服务,不仅仅节约了远距离看病的时间和经济成本,在新冠疫情期间更是降低了病毒传播的可能性。以从业多年的医患交流平台“春雨医生”为例,记者采访了解到,它的问诊方式主要分为两种形式——“快速提问”和“找医生”。“快速提问”是指系统根据用户的基本信息、用户的不适症状进行智能的科室匹配,同时对该时段该科室在线的医生进行众包抢答的推送。抢到问题后,医生便可以与用户进行在线咨询等服务。“找医生”则是用户根据自己的需求,或者根据春雨医生自诊系统提供的建议,自行在平台上寻找自己认为合适的医生进行医疗健康咨询。这种模式让越来越多的用户通过在线问诊接触到互联网医疗服务,一定程度上提高了互联网医疗用户的整体规模和渗透率,也将进一步助推互联网医疗行业的发展。

瑞银证券医药行业分析师谭雅文日前向媒体表示,线上药房和线上问诊两个模式目前来看是有一定可预见性的。根据瑞银对线上问诊和医疗电商两个板块潜在市场规模测算,线上诊疗2025年的潜在市场规模是9000亿元左右,实际市场规模是800亿元左右;药品电商市场的潜在市场规模在1.4万亿元左右,实际市场规模在1000亿元左右。

欧阳日辉认为,当前我国“互联网+医疗”行业发展速度较快,表现为以大数据、云计算、“5G+AI”双核为驱动的智慧医疗模式,具有互联网医院、诊前诊中诊后智能连接和健康管理等多种商业实现方式。随着国家多个政策的出台,大数据、云计算、AI、区块链、5G等新技术发展,业界加快布局“互联网+医疗”,有效推动了数字医疗总体趋势的形成。

在新模式的驱动下,互联网巨头们加速了布局的脚步。据相关媒体报道,2020年8月,字节跳动以数亿元对价全资收购百科名医,正式将触角伸向医疗领域;2020年11月,腾讯医典宣布启动医学科普官计划、大众科普官计划、内容开放计划三大计划,表示要以社交化和场景化普惠大众。据安信证券统计,互联网医疗行业一级市场投融资投资量主要集中于医疗信息化行业。2020年1至11月全球一级市场医疗信息化投融资金额共计378.61亿元,占比47.84%;投融资数量共191笔,占比达54.57%。从国内来看,医疗信息化行业2020年一级市场投融资多达59笔。截至2020年末,港股市场有京东健康、阿里健康与平安好医生;A股市场有以东华软件、创业慧康、卫宁健康、东软集团为首的互联网医疗概念股。有业内人士预计,在未来5至10年,医疗领域最主流的公司将成为数字化医疗企业。

数字医疗未来发展仍须有效监管

建设智慧医疗模式的过程推动了数字健康公司的快速发展。全球市场研究机构CB Insights对数字健康公司的定义是指健康医疗领域中使用软件、技术作为主要竞争力之一的公司,包括疾病诊断、技术驱动的医疗保险平台、用于药物发现的AI工具等。在“互联网+医疗”模式的推动下,数字健康公司正在重塑健康保障领域的各个方面,数字医疗这一领域正在不断成熟。而数字医疗在深度融入公共医疗卫生体系的同时,也在整个健康产业链的各个环节上扮演着越来越重要的角色。

为了更好地推动数字医疗产业的发展,欧阳日辉表示,我们不仅要利用市场机制,激励模式创新,更要积极发挥政府的政策指引与措施激励,进行“政策创新”。要合理规避政策的“反反复复”与“一刀切”现象,增加政策调整空间与适应性,降低政策变动对行业发展的负面效应。国家层面要加大对医药行业机制研究的投入力度,做好机制设计与理论研究,增强政策的可行性与有效性。同时,还应格外重视个人隐私的保护,防止数据外流。

据相关媒体报道,数字医疗的发展也要照顾多个群体的实际需求,譬如老年人。虽然“互联网+”的模式给人们带来很多便利,但老年人往往需要很长时间才能掌握像网上问诊、网上购药一类的信息技术。因此,随着数字医疗的发展,我们更应照顾到老年人难以掌握的问题,通过多种渠道帮助老人迈过医疗健康的“数字鸿沟”。(完)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1647595, encodeId=6ba2164e595d5, content=<a href='/topic/show?id=ad5f3536193' target=_blank style='color:#2F92EE;'>#医药电商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35361, encryptionId=ad5f3536193, topicName=医药电商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca223453562, createdName=liuyong2988, createdTime=Mon Sep 20 18:55:09 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370658, encodeId=12c813e0658d2, content=<a href='/topic/show?id=0fba5e679f1' target=_blank style='color:#2F92EE;'>#数字医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57679, encryptionId=0fba5e679f1, topicName=数字医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3289320, createdName=海豹, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410104, encodeId=cc061410104ca, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542149, encodeId=83cf154214994, content=<a href='/topic/show?id=61ae5812230' target=_blank style='color:#2F92EE;'>#新华社#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58122, encryptionId=61ae5812230, topicName=新华社)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a613357359, createdName=124984edm26暂无昵称, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923586, encodeId=7817923586d5, content=前景不可限量, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210224/ce0d4123440c4a7dbcb2e72458d6c283/7cc60f034a584c3dabbaa659278e106d.jpg, createdBy=82e45441201, createdName=ms7000001204488220, createdTime=Mon Feb 08 00:57:35 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923287, encodeId=049892328eed, content=好前景啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d032482433, createdName=临床设计, createdTime=Sat Feb 06 15:31:22 CST 2021, time=2021-02-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1647595, encodeId=6ba2164e595d5, content=<a href='/topic/show?id=ad5f3536193' target=_blank style='color:#2F92EE;'>#医药电商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35361, encryptionId=ad5f3536193, topicName=医药电商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca223453562, createdName=liuyong2988, createdTime=Mon Sep 20 18:55:09 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370658, encodeId=12c813e0658d2, content=<a href='/topic/show?id=0fba5e679f1' target=_blank style='color:#2F92EE;'>#数字医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57679, encryptionId=0fba5e679f1, topicName=数字医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3289320, createdName=海豹, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410104, encodeId=cc061410104ca, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542149, encodeId=83cf154214994, content=<a href='/topic/show?id=61ae5812230' target=_blank style='color:#2F92EE;'>#新华社#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58122, encryptionId=61ae5812230, topicName=新华社)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a613357359, createdName=124984edm26暂无昵称, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923586, encodeId=7817923586d5, content=前景不可限量, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210224/ce0d4123440c4a7dbcb2e72458d6c283/7cc60f034a584c3dabbaa659278e106d.jpg, createdBy=82e45441201, createdName=ms7000001204488220, createdTime=Mon Feb 08 00:57:35 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923287, encodeId=049892328eed, content=好前景啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d032482433, createdName=临床设计, createdTime=Sat Feb 06 15:31:22 CST 2021, time=2021-02-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1647595, encodeId=6ba2164e595d5, content=<a href='/topic/show?id=ad5f3536193' target=_blank style='color:#2F92EE;'>#医药电商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35361, encryptionId=ad5f3536193, topicName=医药电商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca223453562, createdName=liuyong2988, createdTime=Mon Sep 20 18:55:09 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370658, encodeId=12c813e0658d2, content=<a href='/topic/show?id=0fba5e679f1' target=_blank style='color:#2F92EE;'>#数字医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57679, encryptionId=0fba5e679f1, topicName=数字医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3289320, createdName=海豹, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410104, encodeId=cc061410104ca, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542149, encodeId=83cf154214994, content=<a href='/topic/show?id=61ae5812230' target=_blank style='color:#2F92EE;'>#新华社#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58122, encryptionId=61ae5812230, topicName=新华社)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a613357359, createdName=124984edm26暂无昵称, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923586, encodeId=7817923586d5, content=前景不可限量, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210224/ce0d4123440c4a7dbcb2e72458d6c283/7cc60f034a584c3dabbaa659278e106d.jpg, createdBy=82e45441201, createdName=ms7000001204488220, createdTime=Mon Feb 08 00:57:35 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923287, encodeId=049892328eed, content=好前景啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d032482433, createdName=临床设计, createdTime=Sat Feb 06 15:31:22 CST 2021, time=2021-02-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1647595, encodeId=6ba2164e595d5, content=<a href='/topic/show?id=ad5f3536193' target=_blank style='color:#2F92EE;'>#医药电商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35361, encryptionId=ad5f3536193, topicName=医药电商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca223453562, createdName=liuyong2988, createdTime=Mon Sep 20 18:55:09 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370658, encodeId=12c813e0658d2, content=<a href='/topic/show?id=0fba5e679f1' target=_blank style='color:#2F92EE;'>#数字医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57679, encryptionId=0fba5e679f1, topicName=数字医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3289320, createdName=海豹, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410104, encodeId=cc061410104ca, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542149, encodeId=83cf154214994, content=<a href='/topic/show?id=61ae5812230' target=_blank style='color:#2F92EE;'>#新华社#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58122, encryptionId=61ae5812230, topicName=新华社)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a613357359, createdName=124984edm26暂无昵称, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923586, encodeId=7817923586d5, content=前景不可限量, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210224/ce0d4123440c4a7dbcb2e72458d6c283/7cc60f034a584c3dabbaa659278e106d.jpg, createdBy=82e45441201, createdName=ms7000001204488220, createdTime=Mon Feb 08 00:57:35 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923287, encodeId=049892328eed, content=好前景啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d032482433, createdName=临床设计, createdTime=Sat Feb 06 15:31:22 CST 2021, time=2021-02-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1647595, encodeId=6ba2164e595d5, content=<a href='/topic/show?id=ad5f3536193' target=_blank style='color:#2F92EE;'>#医药电商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35361, encryptionId=ad5f3536193, topicName=医药电商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca223453562, createdName=liuyong2988, createdTime=Mon Sep 20 18:55:09 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370658, encodeId=12c813e0658d2, content=<a href='/topic/show?id=0fba5e679f1' target=_blank style='color:#2F92EE;'>#数字医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57679, encryptionId=0fba5e679f1, topicName=数字医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3289320, createdName=海豹, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410104, encodeId=cc061410104ca, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542149, encodeId=83cf154214994, content=<a href='/topic/show?id=61ae5812230' target=_blank style='color:#2F92EE;'>#新华社#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58122, encryptionId=61ae5812230, topicName=新华社)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a613357359, createdName=124984edm26暂无昵称, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923586, encodeId=7817923586d5, content=前景不可限量, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210224/ce0d4123440c4a7dbcb2e72458d6c283/7cc60f034a584c3dabbaa659278e106d.jpg, createdBy=82e45441201, createdName=ms7000001204488220, createdTime=Mon Feb 08 00:57:35 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923287, encodeId=049892328eed, content=好前景啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d032482433, createdName=临床设计, createdTime=Sat Feb 06 15:31:22 CST 2021, time=2021-02-06, status=1, ipAttribution=)]
    2021-02-08 ms7000001204488220

    前景不可限量

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1647595, encodeId=6ba2164e595d5, content=<a href='/topic/show?id=ad5f3536193' target=_blank style='color:#2F92EE;'>#医药电商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35361, encryptionId=ad5f3536193, topicName=医药电商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca223453562, createdName=liuyong2988, createdTime=Mon Sep 20 18:55:09 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370658, encodeId=12c813e0658d2, content=<a href='/topic/show?id=0fba5e679f1' target=_blank style='color:#2F92EE;'>#数字医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57679, encryptionId=0fba5e679f1, topicName=数字医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3289320, createdName=海豹, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410104, encodeId=cc061410104ca, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542149, encodeId=83cf154214994, content=<a href='/topic/show?id=61ae5812230' target=_blank style='color:#2F92EE;'>#新华社#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58122, encryptionId=61ae5812230, topicName=新华社)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a613357359, createdName=124984edm26暂无昵称, createdTime=Mon Feb 08 04:55:09 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923586, encodeId=7817923586d5, content=前景不可限量, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210224/ce0d4123440c4a7dbcb2e72458d6c283/7cc60f034a584c3dabbaa659278e106d.jpg, createdBy=82e45441201, createdName=ms7000001204488220, createdTime=Mon Feb 08 00:57:35 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923287, encodeId=049892328eed, content=好前景啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d032482433, createdName=临床设计, createdTime=Sat Feb 06 15:31:22 CST 2021, time=2021-02-06, status=1, ipAttribution=)]
    2021-02-06 临床设计

    好前景啊!

    0

相关资讯

“掌上药店”下架一错标为OTC的处方药!炔诺酮片仍标为OTC

近日,南都记者对18家购药App涉嫌违规售卖处方药的情况调查发现,包括“丁香医生”、“360健康”、“掌上药店”、“京东大药房”在内的16家App均销售处方药,部分App购买处方药的流程与网购普通商品无异,无需任何医师或药师审核,即可自助下单购买,而且多家App对处方药进行满减促销。其中,“掌上药店”更是将处方药标为“OTC”(非处方药)来卖。

医药电商上演“三国演义” 药企借势开拓院外市场正当其时

今年“双十一”,又是一个不断打破历史纪录的“双十一”。天猫数据显示,2019天猫全球狂欢节,成交额超过100亿元人民币仅用了96秒,比2018年少了29秒;开场1小时03分59秒,销售额突破1000亿元,比2018年快了43分钟25秒。医药板块也是如此,阿里健康的数据显示,11月11日零点刚过,仅用时2分25秒,天猫医药成交额就突破亿元。与往年“双十一”阿里健康与京东健康“两强相争”不同,今年由于

院外处方药市场未来或现爆发式增长

宏观政策上,国家的大方向是强化医药分开政策,支持处方外流,鼓励互联网+,促进医药电商发展。

继B证C证之后 医药电商A证也取消审批

今年1月份,国务院宣布取消互联网药品交易B证、C证审批,在医药电商圈子里炸开了锅。而就在昨晚,国务院又公布了新一批取消行政许可的事项,其中就包括备受关注的互联网药品交易服务企业(第三方)(简称医药电商A证)审批。

1药网赴美IPO,医药电商上市潮开启?

8月16日,1药网母公司111集团向美国证券交易委员会(SEC)递交招股书,最高募资2亿美元,交易代码为YI,承销商为摩根大通,花旗和中金。

借资本快速扩张 医药零售弱审批、强监管之变

2017年之于医药零售行业,如果简单总结,可概括为政策年、资本年。